Squarepoint Ops LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$57,000
-60.4%
13,227
-61.1%
0.00%
-100.0%
Q1 2021$144,000
+176.9%
33,988
+161.5%
0.00%0.0%
Q3 2020$52,000
-57.7%
12,998
-58.6%
0.00%0.0%
Q4 2019$123,000
-48.1%
31,390
+25.0%
0.00%
-66.7%
Q4 2018$237,000
-68.7%
25,117
-33.2%
0.00%
-66.7%
Q3 2018$757,000
+21.3%
37,602
+75.7%
0.01%
+12.5%
Q2 2018$624,000
+70.5%
21,400
+74.1%
0.01%
+33.3%
Q1 2018$366,000
-39.6%
12,292
-34.7%
0.01%
-45.5%
Q4 2017$606,000
+100.0%
18,820
+29.8%
0.01%
-52.2%
Q1 2016$303,00014,5000.02%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders